You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV, Tuberculosis Infection, Hepatitis C Trial (ART Therapy)

Active, not recruiting
  • HIV Infections
  • +3 more
  • ART Therapy
  • (no location specified)
Dec 16, 2020

Pain, Alcohol Drinking, Acute Pain Trial in Syracuse (Low Alcohol, Moderate Alcohol, Placebo Alcohol)

Completed
  • Pain
  • +3 more
  • Low Alcohol
  • +4 more
  • Syracuse, New York
    Syracuse University
Aug 16, 2022

Hypertension Trial in Boston (Lisinopril, Atenolol)

Withdrawn
  • Hypertension
  • Lisinopril, Atenolol
  • Boston, Massachusetts
    Brigham and Women's Hospital
Apr 7, 2021

Drugs Transfer Across the Placenta

Recruiting
  • Normal Pregnancy
  • Placenta perfusion
  • Paris, France
    CIC Port-Royal-Cochin
Jan 7, 2021

Stroke Trial in Warsaw (core stability in a sitting position and while walking in one place)

Completed
  • Stroke
  • core stability in a sitting position and while walking in one place
  • Warsaw, Masovian District, Poland
    Anna Olczak
May 13, 2021

Growth Hormone Disorder, Adult Growth Hormone Deficiency Trial in Japan (somapacitan, Norditropin)

Completed
Has Results
  • Growth Hormone Disorder
  • Adult Growth Hormone Deficiency
  • Bunkyo-ku, Tokyo, Japan
  • +11 more
Nov 3, 2020

Growth Hormone Disorder, Adult Growth Hormone Deficiency Trial in Worldwide (somapacitan, somatropin, )

Completed
Has Results
  • Growth Hormone Disorder
  • Adult Growth Hormone Deficiency
  • Birmingham, Alabama
  • +116 more
Nov 3, 2020

Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma Trial in United

Completed
Has Results
  • Acute Adult T-Cell Leukemia/Lymphoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Baltimore, Maryland
  • +7 more
Dec 2, 2019

Aging Trial in Bologna (Coenzyme Q10, Selenium, Resveratrol)

Not yet recruiting
  • Aging
  • Coenzyme Q10
  • +5 more
  • (no location specified)
Aug 12, 2022

Central Venous Catheters, Vascular Access Devices, Education Trial in Karabaglar (Lecture, Demo Video, UltrasoundImaging)

Completed
  • Central Venous Catheters
  • +4 more
  • Lecture
  • +3 more
  • Karabaglar, İzmir, Turkey
    Izmir Bozyaka Training and Research Hospital
Jun 2, 2021

Obstetric Anesthesia Experiences in COVID-19 Positive Patients

Completed
  • Covid19
  • Obstetric Anesthesia
  • Anesthesia management
  • Bursa, Yıldırım, Turkey
    University of Health Sciences Turkey, Bursa Yuksek Ihtisas Train
Dec 30, 2020

Primary Immunodeficiency Diseases (PID) Trial in United States (SC treatment with IGSC, 10% with rHuPH20 followed by SC/IGSC,

Completed
Has Results
  • Primary Immunodeficiency Diseases (PID)
  • SC treatment with IGSC, 10% with rHuPH20 followed by SC/IGSC, 10% only (safety)
  • +2 more
  • Cypress, California
  • +10 more
Apr 30, 2021

Covid19 Trial in Ottawa, Scarborough (Oxygen)

Recruiting
  • Covid19
  • Ottawa, Ontario, Canada
  • +1 more
Oct 29, 2021

End Stage Renal Disease, Peritoneal Dialysis Complication Trial in Holbæk (Dapagliflozin 10 MG [Farxiga])

Enrolling by invitation
  • End Stage Renal Disease
  • Peritoneal Dialysis Complication
  • Dapagliflozin 10 MG [Farxiga]
  • Holbæk, Zealand, Denmark
    University Hospital Copenhagen - Holbaek
Feb 11, 2022

Tumor-Infiltrating Lymphocytes and Programmed Cell Death -

Recruiting
  • Breast Cancer
  • +2 more
  • Observational Study
  • Lucknow, Uttar Pradesh, India
    Sanjay Gandhi Postgraduate Institute of Medical Sciences
Feb 11, 2022

Intermediate Risk Prostate Cancer, Castration-resistant Prostate Cancer Trial in Manchester, Oxford (ChAdOx1-MVA 5T4 vaccine,

Unknown status
  • Intermediate Risk Prostate Cancer
  • Castration-resistant Prostate Cancer
  • ChAdOx1-MVA 5T4 vaccine
  • Nivolumab Infusion [Opdivo]
  • Manchester, United Kingdom
  • +1 more
Nov 27, 2020

Metabolic Flexibility Trial in Singapore (Low Protein)

Completed
  • Metabolic Flexibility
  • Low Protein
  • Singapore, Singapore
    Clinical Nutrition Research Centre
Feb 23, 2021

Visfatin and Omentin-1 - Markers of Nutritional Status of

Completed
  • Gestational Diabetes
  • +3 more
  • Acquisition and analysis of milk samples
  • +3 more
  • Wroclaw, Dolnoslaskie, Poland
    Department and Clinic of Neonatology, Jan Mikulicz-Radecki Unive
Jun 21, 2021

Lupus Nephritis, SLE Nephritis Trial (Curcumin Oral Capsule)

Not yet recruiting
  • Lupus Nephritis
  • SLE Nephritis
  • Curcumin Oral Capsule
  • (no location specified)
Feb 3, 2023

Mechanical Ventilation on Lung Development of Alveolar Stage

Completed
  • Mechanical Ventilation
  • Abnormal Lung Development
  • Peak pressure when mechanical ventilation was switched around a reasonable range
  • Shanghai, Shanghai, China
    Department of Anesthesia, Shanghai Xinhua hospital
Aug 10, 2022

Cardiac Arrest Trial in Beijing (no intervention)

Recruiting
  • Cardiac Arrest
  • no intervention
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jun 26, 2023

Severe Facial Deformity Trial in Boston (Facial Allograft Transplantation)

Completed
  • Severe Facial Deformity
  • Facial Allograft Transplantation
  • Boston, Massachusetts
    Brigham & Women's Hospital
Jan 25, 2021

Microbiome Composition and Function Contributes to Cognitive

Recruiting
  • Parkinson Disease
    • San Bernardino, California
      California State University San Bernardino
    Jun 10, 2022

    Meningococcal Infection Trial in Worldwide (blood sampling, bivalent rLP2086)

    Completed
    Has Results
    • Meningococcal Infection
    • blood sampling
    • bivalent rLP2086
    • Chandler, Arizona
    • +55 more
    Mar 26, 2020

    Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia (CLL), Chemo-sensitive Lymphoma Trial in United States (drug,

    Completed
    • Myelodysplastic Syndrome (MDS)
    • +6 more
    • Gainesville, Florida
    • +10 more
    Nov 30, 2020